174 results on '"de Castro, J."'
Search Results
2. Recomendaciones para el diagnóstico radiológico y la valoración de la respuesta terapéutica en el cáncer de pulmón. Consenso nacional de la Sociedad Española de Radiología Médica y la Sociedad Española de Oncología Médica
- Author
-
Ferreirós, J., Cabeza, B., Gayete, Á., Sánchez, M., Torres, M.I., Cobo, M., Isla, D., Puente, J., Reguart, N., and de Castro, J.
- Published
- 2015
- Full Text
- View/download PDF
3. Los clásicos grecolatinos de la Biblioteca Universal de Joaquín Pi y Margall (II)
- Author
-
Castro de Castro, J. David
- Published
- 2017
- Full Text
- View/download PDF
4. Gayo Salustio Crispo, Obras
- Author
-
de Castro, J. David Castro
- Published
- 2018
- Full Text
- View/download PDF
5. Greek and Latin classics in the Biblioteca Universal collection of Joaquin Pi y Margall (I)/Los clasicos grecolatinos de la Biblioteca Universal de Joaquin Pi y Margall (I)
- Author
-
de Castro, J. David Castro
- Published
- 2016
- Full Text
- View/download PDF
6. Problemas resueltos de electrotecnia
- Author
-
A. Hernández, M. Izzeddine, R.M. De Castro, J. Martínez
- Published
- 2014
7. Francisca Moya del Bano, Quevedo y sus ediciones de textos clasicos. Las citas grecolatinas y la biblioteca clasica de Quevedo
- Author
-
de Castro, J. David Castro
- Published
- 2015
8. Estudio de la validez de un equipo de poligrafía respiratoria (BREAS SC–20) para el diagnóstico del síndrome de apneas-hipopneas durante el sueño
- Author
-
Núñez, R., Rey de Castro, J., Socarrás, E., Calleja, J.M., Rubio, R., Aizpuru, F., and Durán-Cantolla, J.
- Published
- 2003
- Full Text
- View/download PDF
9. Adaptación de un 'Listado de verificación' para la realización de procedimientos en las Unidades del Dolor
- Author
-
Trinidad Martín-Arroyo, J.M., Carnota Martín, A.I., Calderón Seoane, E., Benítez Pareja, D., Aragón Poce, F., Martínez Vázquez de Castro, J., and Torres, L.M.
- Published
- 2015
10. Opiáceos en el dolor musculoesquelético crónico: ¿Estamos contra ellos? Respuesta
- Author
-
Neira Reina, F., Ortega García, J.L., Martínez Vázquez de Castro, J., and Torres, L.M.
- Published
- 2009
11. Neuropatía diabética: Eficacia de la amitriptilina y de la gabapentina
- Author
-
Vidal, M. A., Martínez-Fernández, E., Martínez-Vázquez de Castro, J., and Torres, L. M.
- Subjects
Diabetic ,Dolor neuropático ,Amitriptyline ,Diabético ,Amitriptilina ,Gabapentin ,Gabapentina ,Neuropathic pain - Abstract
El dolor neuropático es una forma de dolor crónico con gran repercusión sobre los pacientes. La diabetes mellitus es una de las prinicipales causas de de dolor neuropático. Es uno de los síndromes dolorosos más complejos, con diversos síntomas y signos que fluctúan con el tiempo tanto en su número como en intensidad. Suele asociar clínica acompañante repercutiendo sobre la actividad social y laboral, con la consiguiente disminución de la calidad de vida. Su tratamiento es difícil y, en general, poco satisfactorio, debido a la falta de conocimiento de los mecanismos fisiopatológicos. Los antidepresivos han sido, hasta ahora, los fármacos de primera elección, pero dada su limitada eficacia y efectos secundarios, se han tenido que buscar alternativas terapéuticas. Mediante una búsqueda en la base de datos del Medline, hemos analizado los estudios controlados que estudian la eficacia de la amitriptilina y de la gabapentina en el tratamiento del dolor neuropático del diabético. Los antidepresivos se han considerado, durante años, tratamiento de primera elección en el dolor neuropático del diabético, siendo la amitriptilina el más empleado. Es creciente la importancia de los anticomiciales para el tratamiento de este tipo de dolor, y se apunta a la gabapentina como el más efectivo. Los efectos secundarios anticolinérgicos de la amitriptilina limitan su uso, sobre todo en los pacientes de mayor edad. La gabapentina parece ser un fármaco bien tolerado, siendo los efectos secundarios más frecuentes el mareo y la somonolencia, por lo parece una buena alternativa como tratamiento de primera elección del dolor neuropático en pacientes añosos. Únicamente se han publicado dos estudios controlados y aleatorizados que comparan ambos tratamientos. No obstante, estos estudios no pueden considerarse concluyentes debido al pequeño tamaño muestral. La gabapentina puede considerarse de primera elección en el tratamiento del dolor neuropático del diabético. La elección de uno u otro fármaco debe hacerse de forma individualizada, basándose en la relación riesgo/beneficio. Neuropathic pain is a form of chronic pain that has a great impact on the patients. Diabetes mellitus is one of the major causes of neuropathic pain. It is one of the most complex painful syndromes, with different symptoms and signs that vary over time both in their number and severity. The accompanying clinical signs affect the social and occupational activity of the patient, with the resulting decrease in the quality of life. Its treatment is difficult and, in general, unsatisfactory due to the lack of knowledge regarding its pathophysiological mechanisms. Antidepressants have been, up to now, the first-line drugs, but given its limited effectiveness and side effects, other therapeutic alternatives have been looked for. Through a search in the Medline database, we reviewed controlled trials that study the effectiveness of amitriptyline and gabapentin for the management of painful diabetic neuropathy. Antidepressants have been considered for years the first-line treatment for neuropathic pain in the diabetic patient, amitriptyline being the most widely used. Antiepileptics are increasingly important the management of this type of pain and they are believed to be the most effective ones. The anticolinergic side effects of amitriptyline restrict its use, the most common side effects being dizziness and somnolence, so it seems to be a good alternative as first-line treatment for neuropathic pain in aged patients. Just two controlled and randomized studies have been published that compare both treatments. However, these studies cannot be considered conclusive due to their small sample size. Gabapentin can also be considered a first-line treatment for neuropathic pain in the diabetic. The election of one or the other drug must be made in each individual case based on the risk-benefit relation.
- Published
- 2004
12. Eficacia de la gabapentina y de la amitriptilina en el dolor neuropático del diabético
- Author
-
Vidal, M. A., Martínez-Fernández, E., Martínez-Vázquez de Castro, J., and Torres, L. M.
- Subjects
Diabetic ,Amytriptiline ,Dolor neuropático ,Diabético ,Gabapentine ,Amitriptilina ,Gabapentina ,Neuropathic pain - Abstract
El dolor neuropático es una forma de dolor crónico con gran repercusión sobre los pacientes. La diabetes mellitus es una de las prinicipales causas de dolor neuropático. Es uno de los síndromes dolorosos más complejos, con diversos síntomas y signos que fluctúan con el tiempo tanto en su número como en intensidad. Suele asociar clínica acompañante repercutiendo sobre la actividad social y laboral, con la consiguiente disminución de la calidad de vida. Su tratamiento es difícil y, en general, poco satisfactorio, debido a la falta de conocimiento de los mecanismos fisiopatológicos. Los antidepresivos han sido, hasta ahora, los fármacos de primera elección, pero dada su limitada eficacia y efectos secundarios, se han tenido que buscar alternativas terapéuticas. Mediante una búsqueda en la base de datos del Medline, hemos analizado los estudios controlados que estudian la eficacia de la amitriptilina y de la gbapentina (GBP) en el tratamiento del dolor neuropático del diabético. Los antidepresivos se han considerado, durante años, tratamiento de primera elección en el dolor neuropático del diabético, siendo la amitriptilina el más empleado. Es creciente la importancia de los anticomiciales para el tratamiento de este tipo de dolor, y se apunta a la GBP como el más efectivo. Los efectos secundarios anticolinérgicos de la amitriptilina limitan su uso, sobre todo en los pacientes de mayor edad. La GBP parece ser un fármaco bien tolerado, siendo los efectos secundarios más frecuentes el mareo y la somnolencia, por lo que parece una buena alternativa como tratamiento de primera elección del dolor neuropático en pacientes añosos. Únicamente se han publicado dos estudios controlados y aleotorizados que comparan ambos tratamientos. No obstante, estos estudios no pueden considerarse concluyentes debido al pequeño tamaño muestral. La GBP puede considerarse de primera elección en el tratamiento del dolor neuropático del diabético. La elección de uno u otro fármaco debe hacerse de forma individualizada, basándose en la relación riesgo/beneficio. Neuropathic pain is a type of chronic pain that has a great impact on the patients. Diabetes mellitus is one of the main causes of neuropathic pain. It is one of the most complex pain syndromes, with diverse symptoms and signs that change over time both in number and severity. It is usually associated to clinical manifestations that interfere with social and job activity, with the resulting impairment of quality of life. Its treatment is difficult and, in general, scarcely satisfactory due to the lack of knowledge regard-ing its physiopathological mechanisms. Antidepressants have been considered until now as the first-line drugs, but due to their limited effectiveness and their side effects, therapeutic alternatives have been looked for. Through a search in the Medline database, we reviewed controlled trials that have studied the effectiveness of amytriptiline and gabapentine (GBP) for the management of diabetic neuropathic pain. For years, antidepressants have been considered the best drugs for this type of pain, amytriptiline being the most frequently used. Currently, anti-epileptics are being increasingly used for the management of this type of pain, and GBP seems to be the most effective one. Anticholinergic side effects of the amytriptiline restrict its use, particularly in aged patients. GBP seems to be a well-tolerated drug, with dizziness and somnolence as its most frequent side effects, so it seems to be a good alternative as first-line therapy for neuropathic pain in aged patients. Only two controlled and randomized studies have been published that compare both treatments. However, these studies cannot be considered conclusive due to their small sample size. GBP can be considered the first-line treatment for diabetic neuropathic pain. The medication must be decided individually for each patient, based on the risk-benefit ratio.
- Published
- 2004
13. Efectos de la intercambiabilidad de fentanilo transdérmico
- Author
-
Torres, L.M., Collado, F., Martínez-Vázquez de Castro, J., Calderón, E., Sánchez-Pardo, J., Molano, J.L., and del Álamo, C.
- Published
- 2009
- Full Text
- View/download PDF
14. Sobre la teoría de las áreas monetarias óptimas
- Author
-
Fernández de Castro, J.
- Subjects
Economía - Published
- 1973
15. Diferencias entre sexos en la experimentación y consumo de tabaco por niños, adolescentes y jóvenes
- Author
-
Barrueco, M., Cordovilla, R., Hernández Mezquita, M.A., de Castro, J., González, J.M., Rivas, P., Fernández, J.L., and Gómez, F.
- Published
- 1998
- Full Text
- View/download PDF
16. Cumplimiento de la legislación antitabaco en instituciones oficiales
- Author
-
Cordovilla, R., Barrueco, M., González Ruiz, J.M., Hernández, M.A., de Castro, J., and Gómez, F.
- Published
- 1997
- Full Text
- View/download PDF
17. Polimorfismos en el gen dihidropirimidina dehidrogenasa (DPYD) y citidina deaminasa (CDA) como factores pronóstico en pacientes con cáncer gástrico resecados tratados con quimioterapia adyuvante con fluoropirimidinas
- Author
-
Muñoz García, Carmen, Grau de Castro, Joan Josep, Torres Gallardo, Begoña, Universitat de Barcelona. Departament d'Anatomia i Embriologia Humana, and Grau de Castro, J. J.
- Subjects
Quimioteràpia del càncer ,Quimioteràpia adjuvant ,Aparell digestiu ,Polimorfisme genètic ,Càncer gàstric ,Cancer chemotherapy ,Genetic polymorphisms ,Ciències de la Salut ,Digestive organs ,Tegafur - Abstract
ESTUDIO: Se sabe que DPYD interviene en procesos catabólicos ó de degradación del 5-fluorouracilo, así como el enzima CDA participa en procesos anabólicos, al proveer de sustrato a la timidilato sintetasa para la síntesis de DNA, y por analogía, en la síntesis de RNA. Por lo tanto, la incorporación de la molécula de 5-FU por semejanza a la molécula de uracilo en procesos anabólicos significa el freno en la síntesis de DNA y de RNA tumoral, al "engañar" el fármaco a los enzimas de estas vías.OBJETIVOS: 1. Analizar polimorfismos en los genes dihidropirimidina dehidrogenasa (DPYD) y citidina deaminasa (CDA); 2. Determinar si estos polimorfismos aumentan o disminuyen la actividad del enzima; y 3. Comprobar si estos polimorfismos están implicados en la supervivencia de pacientes tratados con quimioterapia adyuvante con Tegafur. MÉTODOS: Análisis de polimorfismos por discriminación alélica de muestras parafinadas de 53 pacientes con cáncer gástrico con seguimiento por el Servicio de Oncologia del Hospital Clinic de Barcelona entre mayo de 1995 y noviembre de 2003 que recibieron quimioterapia adyuvante con Tegafur, un profármaco del 5-fluorouracilo y para DPYD Ile543Val (A/G), DPYD Arg29Cys (C/T) y CDA Lys27Gln (A/C). CONCLUSIONES: Polimorfismos en DPYD Ile543Val, DPYD Arg29Cys y CDA Lys27Gln pueden predecir el pronóstico, supervivencia y toxicidad de pacientes con cáncer gástrico tratados con quimioterapia adyuvante con 5-FU. Polimorfismos en DPYD inducen deficiencia en este gen, dando lugar a una actividad aumentada de los derivados de 5-fluorouracil con posible toxicidad, y en concreto se ha observado una mayor supervivencia y significancia estadística para pacientes con DPYD Ile543Val A/G ó G/G. También se observó significancia estadística en pacientes homocigotos para la combinación de DPYD Arg29Cys más CDA Lys27Gln frente a heterocigotos. La asociación de un tercer polimorfismo (DPYD Ile543Val) no tuvo correlación clinica. Las frecuencias alélicas para DPYD Arg29Cys diferían de los valores de las bases de datos obtenidas por Internet para el resto de la población mundial., "Dihydropyrimidine dehydrogenases (DPYD) and cytidine deaminase (CDA) gene polymorphisms as genomic predictors of clinical outcome in resected gastric cancer patients (GCP) treated with fluoropyrimidine based chemotherapy".BACKGROUND: Single nucleotide polymorphisms (SNPs) of DPYD gene induces deficiency in this gene resulting in a increased activity of 5-fluorouracil derivates in treatment of colorectal cancer patients. In GCP has not been previously analysed.OBJECTIVES: 1. To analyse polymorphisms in the genes dihydropyrimidine dehydrogenase (DPYD) and cytidine deaminase (CDA); 2. To prove if these polymorphisms increase or decrease the activity of the enzyme; and 3. To observe if these polymorphisms are involved in the survival of patients treated with adjuvant chemotherapy with Tegafur.METHODS: Analysis of polymorphisms by allelic discrimination of paraffin-embedded biopsies from 53 consecutive GCP of the Department of Oncology in the Hospital Clinic of Barcelona in the period of time between May 1985 and November 2003, who received adjuvant chemotherapy with Tegafur, one prodrug of 5-fluorouracil, for DPYD Ile543Val (A/G), DPYD Arg29Cys (C/T) and CDA Lys27Gln (A/C).CONCLUSIONS: Polymorphisms of DPYD Ile543Val, DPYD Arg29Cys and CDA Lys27Gln predict outcome, survival and toxicity of GCP treated with 5-FU based adjuvant chemotherapy, with major survival with statistic significance for patients DPYD Ile543Val A/G ó G/G and for homozygous patients for the combination of DPYD Arg29Cys plus CDA Lys27Gln front heterozygous. The association of one third polymorphism (DPYD Ile543Val) hadn't clinic correlation.
- Published
- 2008
18. [New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
- Author
-
Isla D, Lozano MD, Paz-Ares L, Salas C, de Castro J, Conde E, Felip E, Gómez-Román J, Garrido P, and Belén Enguita A
- Subjects
- Humans, Protein-Tyrosine Kinases, Consensus, Biomarkers, Tumor genetics, Proto-Oncogene Proteins genetics, Medical Oncology, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung therapy, Lung Neoplasms pathology
- Abstract
Non-small cell lung cancer (NSCLC) presents the greatest number of identified therapeutic targets, some of which have therapeutic utility. Currently, detecting EGFR, BRAF, KRAS and MET mutations, ALK, ROS1, NTRK and RET translocations, and PD-L1 expression in these patients is considered essential. The use of next-generation sequencing (NGS) facilitates precise molecular diagnosis and allows the detection of other emerging mutations, such as the HER2 mutation and predictive biomarkers for immunotherapy responses. In this consensus, a group of experts in the diagnosis and treatment of NSCLC selected by the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM) have evaluated currently available information and propose a series of recommendations to optimize the detection and use of biomarkers in daily clinical practice., (Copyright © 2023 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
19. Deceased donor kidney procurement: Systematic review of the surgical technique.
- Author
-
Polanco Pujol L, Caño Velasco J, González García J, Herranz Amo F, Lledó García E, Bueno Chomón G, Mayor de Castro J, Aragón Chamizo J, Arnal Chacón G, Moralejo Gárate M, Subirá Ríos D, Diez Cordero JM, Durán Merino R, and Hernández Fernández C
- Subjects
- Humans, Graft Survival, Kidney surgery, Tissue Donors, Kidney Transplantation, Tissue and Organ Procurement
- Abstract
Introduction: Kidney procurement procedure must be carried out following a standardized technique in order to optimize kidney grafts for their subsequent implantation., Objectives: Review of the available literature on kidney procurement procedure., Material and Methods: Narrative review of the available evidence on deceased donor kidney procurement technique after a search of relevant manuscripts indexed in PubMed, EMBASE and Scielo written in English and Spanish., Results: Deceased donor kidney procurement can be divided into two groups, donation after brain death (DBD) and donation after circulatory death (DCD). Kidney procurement in DBD frequently includes other chest and/or abdominal organs, requiring multidisciplinary surgical coordination. During the harvesting procedure, the renal vascular pedicle must remain intact for subsequent implantation and reduced ischemia time., Conclusions: Adequate execution and perfect knowledge of the technique for surgical removal and anatomy reduces the rate of graft losses associated to inadequate harvesting techniques., (Copyright © 2022 AEU. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
20. Laparoscopic nephron sparing surgery and radical nephrectomy in cT1 renal tumors. Comparative analysis of complications and survival.
- Author
-
Luis-Cardo A, Herranz-Amo F, Rodríguez-Cabero M, Quintana-Álvarez R, Esteban Labrador L, Rodríguez-Fernández E, Mayor-de Castro J, Barbas Bernardos G, Ramírez Martín D, and Hernández-Fernández C
- Subjects
- Humans, Nephrectomy, Nephrons pathology, Obesity, Retrospective Studies, Carcinoma, Renal Cell, Kidney Neoplasms pathology, Laparoscopy
- Abstract
Introduction and Objectives: Comparative analysis of postoperative complications and survival between laparoscopic partial nephrectomy (PN) and radical nephrectomy (RN) in cT1 renal cell carcinoma (RCC)., Material and Method: Retrospective study of patients with two kidneys and single renal tumor cT1 treated in our center between 2005 and 2018 by laparoscopic PN or RN., Results: 372 patients met the inclusion criteria for the study. RN was performed in 156 (41.9%) patients and PN in 216 (58.1%). Clavien Dindo III-V complications were observed in 10 (4,6%) PN and 6 (3,9%) RN patients (p = 0.75). The comorbidity Charlson index (CCI) was identified as an independent predictor variable of complications (p = 0.02) and surgical approach did not affect multivariate analysis. Estimated overall survival (OS) was 81.2% and 56.8% at 5 and 10 years in the RN group and 90.2% and 75.7% in the PN group, respectively (p = 0.0001). Obesity (HR 2.77, p = 0.01), CCI ≥ 3 (HR 3.69, p = 0.001) and glomerular filtration rate (GFR) <60 mL/min/1.73 m
2 at discharge (HR 1.87, p = 0.03) were identified as predictors of overall mortality. Nephrectomy approach showed no influence on OS. Estimated recurrence-free survival (RFS) was 86.1% at 5 and 10 years in the RN group and 93.5% and 83.6% in the PN group, respectively (p = 0.22)., Conclusions: Laparoscopic PN is not inferior to RN in terms of oncologic and surgical safety in cT1 RCC. Nephrectomy approach did not influence patient OS, however, obesity, CCI ≥ 3 and GFR <60 mL/min/1.73 m2 at discharge did behave as predictors., (Copyright © 2021 AEU. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
21. [Biomarkers in testicular cancer.]
- Author
-
Mayor-de-Castro J, Aragón-Chamizo J, Caño-Velasco J, and Hernández-Fernández C
- Subjects
- Chorionic Gonadotropin, Humans, L-Lactate Dehydrogenase, Male, Prognosis, Neoplasms, Germ Cell and Embryonal diagnosis, Testicular Neoplasms diagnosis, Testicular Neoplasms pathology
- Abstract
Objective: To review the current situationof biomarkers used in the diagnosis, prognosis,treatment response and relapse of testicular cancer., Methods: A non systematic review was performedof clinical guidelines and articles published within thelast years regarding biomarkers in testicular cancer., Results: The most commonly used biomarkersare alphafetoprotein (AFP) and beta human corionicgonadotropin (β-HCG).The enzyme lactate dehydrogenase (LDH) is presentin multiple tissues and is elevated in advancedgerminal tumors. A few micro molecules of RNA (micro-RNA) have demonstrated to be specifically elevatedin testicular germinal tumors. However, its clincalbenefit, as well as its standardization is currently underinvestigation., Conclusions: Classic biomarkers AFP, β-HCG,and LDH are of some utility confirming the diagnosisif they are elevated. However, its limited sensibility isnot enough to rely the diagnosis on themselves. Thereare promising results with Micro-RNA but its daily usedoes not seem imminent.
- Published
- 2022
22. [Pulmonary adenocarcinoma with double mutation EGFR: L858R and G719X].
- Author
-
Cruz Castellanos P, Gutiérrez Sainz L, Esteban MI, and de Castro J
- Subjects
- Adenocarcinoma of Lung diagnostic imaging, Female, Humans, Lung Neoplasms diagnostic imaging, Middle Aged, Tomography, X-Ray Computed, Adenocarcinoma of Lung genetics, Genes, erbB-1 genetics, Lung Neoplasms genetics, Mutation
- Abstract
Lung cancer with EGFR mutation is rare in our country, with an estimated incidence of 7-10%. It is well known that, in this type of disease, specific inhibitors should be used, as they increase patient survival and therefore prognosis. So-called tumour heterogeneity, the possibility of various mutations concurring in the same tumour, is currently being debated. We present a case of a double mutation of EGFR and discuss treatment, management and possible implications., (Copyright © 2020 Sociedad Española de Anatomía Patológica. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. [Retrospective study of lung carcinoid: experience in a third level Spanish hospital].
- Author
-
Cruz Castellanos P, Sánchez Cabrero D, Esteban MI, and de Castro J
- Subjects
- Aged, Ex-Smokers statistics & numerical data, Female, Humans, Male, Middle Aged, Neoplasm Staging, Non-Smokers statistics & numerical data, Retrospective Studies, Smokers statistics & numerical data, Spain, Survival Analysis, Tertiary Care Centers, Carcinoid Tumor chemistry, Carcinoid Tumor mortality, Carcinoid Tumor pathology, Carcinoid Tumor surgery, Lung Neoplasms chemistry, Lung Neoplasms mortality, Lung Neoplasms pathology, Lung Neoplasms surgery
- Abstract
Introduction: Pulmonary carcinoids are relatively rare neuroendocrine neoplasms, accounting for only 1-2% of malignant thoracic tumours. We describe our experience in the management and follow-up of such an infrequent tumour, with special emphasis on possible problems that might arise., Patients and Methods: We present a descriptive retrospective study of all patients diagnosed with carcinoid tumour between January 2013 and January 2018. Demographic, histological and clinical data were collected and analyzed. Survival was recorded. SPSS version 21 was used for the statistical analysis., Results: 42 patients with an average age of 66.26 years were included. The mean period of follow-up was 60 months and the average survival 59.12 months. The only statistically significant factor related to an improved survival time was tumour stage at diagnosis., Conclusion: Carcinoid tumours are infrequent, which makes the objective collecting of data difficult. For this reason, we hope that the present study will contribute to a better understanding of their evolution., (Copyright © 2020 Sociedad Española de Anatomía Patológica. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
24. Comparison between laparoscopic and open prostatectomy: Oncological progression analysis.
- Author
-
Martínez-Holguín E, Herranz-Amo F, Mayor de Castro J, Polanco-Pujol L, Hernández-Cavieres J, Subirá-Ríos D, Moralejo-Gárate MI, Aragón-Chamizo J, and Hernández-Fernández C
- Subjects
- Aged, Cohort Studies, Disease Progression, Humans, Male, Margins of Excision, Middle Aged, Neoplasm Recurrence, Local, Prostatic Neoplasms pathology, Retrospective Studies, Treatment Outcome, Laparoscopy, Prostatectomy methods, Prostatic Neoplasms surgery
- Abstract
Introduction: There are very few Spanish studies that compare oncological outcomes following radical prostatectomy (RP) based on surgical approach, and their methodology is not appropriate., Objective: To compare oncological outcomes in terms of surgical margins (SM) and biochemical recurrence (BR) between open radical prostatectomy (ORP) and laparoscopic radical prostatectomy (LRP)., Material and Methods: Comparison of two cohorts (307 with ORP and 194 with LRP) between 2007-2015. Surgical margin status was defined as positive or negative, and BR as a PSA rise of >0.4 ng/ml after surgery. To compare the qualitative variables, we employed the Chi-squared test, and ANOVA was used for quantitative variables. We performed a multivariate analysis using logistic regression to evaluate the predictive factors of SM, and a multivariate analysis using Cox regression to evaluate the predictive factors of BR., Results: Gleason 7 (3+4) was determined in the surgical specimens of 43.5% of patients, and 31.7% had positive SM. The most frequent pathological stage was pT2c, on the 61.9% of the cases. No significant differences were found between both groups, except for extracapsular extension (p=0.001), more frequent in LRP. The median follow-up was 49 months. BR was seen in the 23% of patients, without significant differences between groups. In the multivariable analysis, only the D'Amico risk group behaved as an independent predictive factor of positive SM, and Gleason score and positive SM acted as independent predictive factors of BR., Conclusion: The surgical approach did not influence SM status or BR., (Copyright © 2020 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Survival analysis of patients with prostate cancer and unfavorable risk factors treated with radical prostatectomy and salvage radiotherapy after biochemical recurrence and persistence.
- Author
-
Barbas Bernardos G, Herranz Amo F, González San Segundo C, Caño Velasco J, Subirá Ríos D, Moralejo Gárate M, Mayor de Castro J, Aragón Chamizo J, and Hernández Fernández C
- Subjects
- Aged, Humans, Male, Middle Aged, Neoplasm Recurrence, Local blood, Neoplasm Recurrence, Local mortality, Prostate-Specific Antigen blood, Prostatectomy, Prostatic Neoplasms blood, Prostatic Neoplasms mortality, Retrospective Studies, Risk Factors, Salvage Therapy, Survival Analysis, Neoplasm Recurrence, Local radiotherapy, Neoplasm Recurrence, Local surgery, Prostatic Neoplasms radiotherapy, Prostatic Neoplasms surgery
- Abstract
Objective: Survival analysis of patients with prostate cancer (PCa) with adverse prognostic factors (APF) treated with radical prostatectomy (RP) and salvage radiotherapy (SRT) after biochemical recurrence (BR) or biochemical persistence (BP)., Materials and Methods: Retrospective analysis of 446 patients with at least one of the following APF: Gleason score ≥8, pathologic stage ≥pT3 and/or positive surgical margins. BR criteria used was PSA level over 0.4ng/ml. A survival analysis using Kaplan-Meier was performed to compare the different variable categories with log-rank test. In order to identify risk factors for SRT response and cancer specific survival (CSS) we performed univariate and multivariate analyses using Cox regression., Results: Mean follow up: 72 (IQR 27-122) months, mean time to BR: 42 (IQR 20-112) months, mean PSA level at BR: 0.56 (IQR 0.42-0.96). BR was present in 36.3% of the patients. Biochemical response to SRT was observed in 121 (75.7%) patients. Recurrence-free survival (RFS) rates after SRT at 3, 5, 8 and 10years were 95.7%, 92.3%, 87.9%, and 85%; overall survival (OS) rates after 5, 10 and 15years was 95.6%, 86.5% and 73.5%, respectively. CSS rates at 5, 10 and 15years were 99.1%, 98.1% and 96.6%. Only time to BR <24months (HR=2.55, P=.01) was identified as an independent risk factor for RFS after SRT., Conclusions: In these patients, RP only controls the disease in approximately half of the cases. Multimodal sequential treatment (RP+SRT when needed) increases this control, achieving high CSS rates and biochemical control in over 87% of the patients. Patients with time to recurrence >24months responded better to rescue treatment., (Copyright © 2020 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
26. External iliac artery dissection with prosthesis replacement in renal transplantation.
- Author
-
Quintana Álvarez R, Herranz Amo FB, Mayor de Castro J, and Hernández Fernández C
- Subjects
- Humans, Male, Middle Aged, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation, Iliac Artery, Kidney Transplantation, Postoperative Complications surgery, Vascular Diseases surgery
- Published
- 2020
- Full Text
- View/download PDF
27. Analysis of recurrence trends according to risk groups after renal cancer nephrectomy.
- Author
-
Polanco Pujol L, Herranz Amo F, Caño Velasco J, Moralejo Gárate M, Subirá Ríos D, Barbas Bernardos G, Mayor de Castro J, Aragón Chamizo J, Husilllos Alonso A, and Hernández Fernández C
- Subjects
- Aged, Humans, Middle Aged, Retrospective Studies, Risk Factors, Carcinoma, Renal Cell epidemiology, Carcinoma, Renal Cell surgery, Kidney Neoplasms epidemiology, Kidney Neoplasms surgery, Neoplasm Recurrence, Local epidemiology, Nephrectomy
- Abstract
Introduction: Recurrence trends after renal cell cancer nephrectomy are not clearly defined., Objective: To evaluate recurrence trends according to recurrence risk groups (RRG)., Material and Method: Retrospective analysis of 696 patients with renal cell cancer treated with nephrectomy between 1990-2010. Three RRG were defined according to the presence of anatomopathological variables (pTpN stage, nuclear grade, tumor necrosis [TN], sarcomatoid differentiation [SD], positive resection margin [RM]): -Low RG (LRG): pT1pNx-0 G1-4, pT2pNx-0 G1-2; no TN, SD and/or RM (+). -Intermediate RG (IRG): pT2pNx-0 G3-4; pT3-4pNx-0 G1-2; LRG with TN. -High RG (HRG): pT3-4pNx-0 G3-4; pT1-4pN+; IRG with TN and/or SD; LRG with SD and/or RM (+). The Kaplan-Meier method has been used to evaluate recurrence-free survival as a function of RRG. The log-rank test was used to evaluate differences between survival curves., Results: The median follow-up was 105 (IQR 63-148) months. Of the total series, 177 (25.4%) patients presented recurrence: distant 15.9%, local 4.9% and 4.6% distant and local. The recurrence rate varied according to the RRG with values of 72.9% for HRG, 16.9% for IRG and 10.2% for LRG (p=.0001). Most cases in LRG presented single organ recurrence (72.2%) (p=.006). The LRG experienced recurrence as single metastasis in 50% of cases, compared to 30% and 18.6% in IRG and HRG, respectively (p=.009). The most common sites of recurrence were lung and abdomen. Lung recurrence predominated in the HRG (72.9%) (p=.0001) and abdominal, in the LRG (83.3%) with a tendency to significance (p=.15)., Conclusions: Recurrence rates (especially bone and lung) increase with higher RG. Single organ recurrences and single metastases are more frequent in LRG., (Copyright © 2020 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
28. Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients.
- Author
-
Rosas-Alonso R, Galera R, Sánchez-Pascuala JJ, Casitas R, Burdiel M, Martínez-Cerón E, Vera O, Rodriguez-Antolin C, Pernía O, De Castro J, García-Rio F, and Ibanez-de-Cáceres I
- Subjects
- DNA Methylation, Humans, Prospective Studies, Emphysema, MicroRNAs genetics, Pulmonary Disease, Chronic Obstructive genetics
- Abstract
Introduction: MicroRNA-7 (miR-7) has a suppressive role in lung cancer and alterations in its DNA methylation may contribute to tumorigenesis. As COPD patients with emphysema have a higher risk of lung cancer than other COPD phenotypes, we compared the miR-7 methylation status among smoker subjects and patients with various COPD phenotypes to identify its main determinants., Methods: 30 smoker subjects without airflow limitation and 136 COPD patients without evidence of cancer were recruited in a prospective study. Clinical and functional characteristics were assessed and patients were classified into: frequent exacerbator, emphysema, chronic bronchitis and asthma COPD overlap (ACO). DNA collected from buccal epithelial samples was isolated and bisulfite modified. miR-7 methylation status was evaluated by quantitative methylation-specific polymerase chain reaction (qMSP)., Results: miR-7 Methylated levels were higher in COPD patients than in smokers without airflow limitation (23.7±12.4 vs. 18.5±8.8%, p=0.018). Among COPD patients, those with emphysema had higher values of methylated miR-7 (27.1±10.2%) than those with exacerbator (19.4±9.9%, p=0.004), chronic bronchitis (17.3±9.0%, p=0.002) or ACO phenotypes (16.0±7.2%, p=0.010). After adjusting for clinical parameters, differences between emphysematous patients and those with other phenotypes were retained. In COPD patients, advanced age, mild-moderate airflow limitation, reduced diffusing capacity and increased functional residual capacity were identified as independent predictors of methylated miR-7 levels., Conclusion: The increase of miR-7 methylation levels experienced by COPD patients occurs mainly at the expense of the emphysema phenotype, which might contribute to explain the higher incidence of lung cancer in these patients., (Copyright © 2019 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
29. [Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
- Author
-
López-Ríos F, Paz-Ares L, Sanz J, Isla D, Pijuan L, Felip E, Gómez-Román JJ, de Castro J, Conde E, and Garrido P
- Subjects
- Anaplastic Lymphoma Kinase genetics, B7-H1 Antigen analysis, Biomarkers, Tumor analysis, Biopsy, Carcinoma, Non-Small-Cell Lung chemistry, Carcinoma, Non-Small-Cell Lung pathology, ErbB Receptors genetics, Genetic Markers, High-Throughput Nucleotide Sequencing, Humans, Liquid Biopsy, Lung Neoplasms chemistry, Lung Neoplasms pathology, Medical Oncology, Membrane Glycoproteins genetics, Mutation, Pathology, Clinical, Protein-Tyrosine Kinases genetics, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins c-met genetics, Proto-Oncogene Proteins c-ret genetics, Receptor, trkA genetics, Receptor, trkB genetics, Receptor, trkC genetics, Societies, Medical, Spain, Biomarkers, Tumor genetics, Carcinoma, Non-Small-Cell Lung genetics, Consensus, Lung Neoplasms genetics
- Abstract
In 2011, the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) initiated a joint project to establish guidelines for biomarker testing in patients with advanced non-small-cell lung cancer based on the information available at the time. As this field is constantly evolving, these guidelines were updated in 2012 and 2015 and now in 2019. Current evidence suggests it should be mandatory to test all patients with this kind of advanced lung cancer for EGFR and BRAF mutations, ALK and ROS1 rearrangements and PD-L1 expression. The growing need to study other emerging biomarkers has promoted the routine use of massive sequencing (next-generation sequencing, NGS). However, the coordination of every professional involved and the prioritisation of the most suitable tests and technologies for each case remain a challenge., (Copyright © 2020 Sociedad Española de Anatomía Patológica. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
30. [Effect of surgical approach on radical nephrectomy outcomes: Comparative study between open and laparoscopic nephrectomy.]
- Author
-
Barbas-Bernardos G, Herranz-Amo F, Caño-Velasco J, Gonzalo-Balbás Á, Subirá-Ríos D, Moralejo-Gárate M, Mayor-de Castro J, Escribano-Patiño G, Rodríguez-Fernández E, Aragón-Chamizo J, and Hernández Fernández C
- Subjects
- Humans, Neoplasm Recurrence, Local, Nephrectomy, Retrospective Studies, Treatment Outcome, Carcinoma, Renal Cell surgery, Kidney Neoplasms surgery, Laparoscopy
- Abstract
Objective: The aim of this study is to evaluate the influence of laparoscopy in patients with renal cancer treated with radical nephrectomy in terms of surgical time, hospital stay, postoperative complications and survival.MATERIAL AND METHODS: Retrospective study of 570 patients with renal cancer treated with radical nephrectomyin stage ≤pT3a. Differences between groups were analysed using ANOVA test for quantitative variables and Chi squared test for qualitative. In order to evaluate possible risk factors for longer hospital stay and surgical time, multivariate analysis was performed (lineal regression). For complications we performed binary logistic regression. Overall survival (OS), recurrence free survival (RFS) and cancer specific survival (CSS) were estimated using Kaplan Meier and compared using Log Rank test. Univariate and multivariate analysis was performed using Cox regression in order to identify independent risk factors for overall, cancer specific and recurrence mortality., Results: Two cohorts: 361 (63.3%) open radical nephrectomies (ORN) and 209 (36.7%) laparoscopic (LRN). Surgical time was longer in LRN (p=0.001) globally. After the period when the learning curve was over these differences were no longer significant. Hospital stay was shorter in LRN (p=0.0001). cT stage (p=0.005) and surgical access (p=0.001) acted as independent risk factors for longer surgical time. 33,5% (121 patients) of the ORN had some sort of postoperative complication vs. 11% (23 patients) in the LRN group (p=0.0001). These differences were observed in the Clavien-Dindo's grade II group. Independent risk factors for postoperative complications observed were: ASA≥III (OR=1.82, p=0.004) and stage pT3a (OR=2.29,p=0.0001). Laparoscopy acted as a protective factor for complications (OR=0,26, p=0.0001). Surgical access did not influence RFS (HR=0.87, p=0.50), CSS(HR=0.69, p=0.12)., Conclusions: Laparoscopic access to RN in patients with renal cancer in ≤pT3a stage increased surgical time only in the first years, reduced hospital stayand postoperative complications and did not influence RFS, OS or CSS.
- Published
- 2020
31. [Protein expression of PD-L1 and clinico-pathological data in a cohort of 53 patients with resectable non small cell lung cancer (NSCLC). Concordance between clones (22C3 and 28-8) and observers. Correlation and prognostic value of clinico-pathological data].
- Author
-
Esteban-Rodríguez I, Ruiz Bravo-Burguillos E, Rosas R, Losantos I, Rodríguez-Antolín C, and de Castro J
- Subjects
- Adenocarcinoma chemistry, Adenocarcinoma classification, Adenocarcinoma pathology, Adenocarcinoma therapy, Aged, Carcinoma, Non-Small-Cell Lung classification, Carcinoma, Non-Small-Cell Lung pathology, Carcinoma, Non-Small-Cell Lung therapy, Carcinoma, Squamous Cell chemistry, Carcinoma, Squamous Cell classification, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell therapy, Female, Humans, Immunity, Cellular, Immunotherapy, Lung Neoplasms classification, Lung Neoplasms pathology, Lung Neoplasms therapy, Male, Neoplasm Grading, Pathologists, Patient Selection, Prognosis, Retrospective Studies, B7-H1 Antigen analysis, Biomarkers, Tumor analysis, Carcinoma, Non-Small-Cell Lung chemistry, Lung Neoplasms chemistry
- Abstract
Introduction: 85% of lung cancers are non-small cell carcinomas (NSCLC), the majority of which are diagnosed in an advanced stage. Immunotherapy has changed the treatment pattern for these tumors and created the need to find a marker for patient selection. Although not ideal, PD-L1 is the biomarker currently used in clinical practice., Material and Methods: Retrospective review by two pathologists of 53 cases of NSCLC from 2005 to 2007 in Hospital Universitario La Paz, using the WHO 2015 classification studying PD-L1 with clones 22C3 and 28-8. The consistency between observers and clones was assessed and all data studied were correlated with survival rates., Results: We found a prevalence of PD-L1 expression in tumor cells (TC) similar to that previously reported in the literature and a very good consistency between clones in the evaluation of TC and immune cells (ICC 0.99-0.93, p<.001). Interobserver concordance was very good in the evaluation of TC (ICC 0.902, 95% CI: 0.836-0.942, p<.001 for clone 22C3 and ICC 0.927, 95% CI: 0.877-0.957, p<.001 for clone 28-8) and poor for immune cells (ICC of 0.413, 95% CI: 0.163-0.613, p=.001 with clone 22C3 and ICC of 0.313, 95% CI: 0.053-0.534, p=.010 with clone 28-8). Subtype and histological grade were the only variables related to prognosis., Conclusions: The clones of PD-L1 22C3 and 28-8 are equivalent and there is good interobserver consistency in the evaluation of TC but not in immune cells., (Copyright © 2019 Sociedad Española de Anatomía Patológica. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
32. [Factors associated with daytime sleepiness in public transportation drivers in Lima Metropolitan area].
- Author
-
Peña-Prado K, Rey de Castro J, and Talaverano-Ojeda A
- Subjects
- Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Humans, Logistic Models, Male, Middle Aged, Peru, Time Factors, Young Adult, Automobile Driving statistics & numerical data, Sleep physiology, Sleepiness
- Abstract
Objective: . To determine the frequency of sleepiness and its associated factors in public transportation drivers in Lima metropolitan area., Materials and Methods: . Transversal analytical study carried out on drivers between 18 and 65 years old who work in a public transportation company registered in the Municipality of Lima. Sleepiness was assessed using a version of the Epworth Sleepiness Scale validated in Peru. The variables that could behave as associated factors were obtained by a data collection sheet. Logistic regression was used to estimate the magnitude of the association between sleepiness and variables considered as associated factors., Results: . Four hundred forty (440) drivers were included, median age was 38.0 years and the majority (99.3%) were males. From the total number of drivers, 17.7% (78) experienced daytime sleepiness. A significant association was found between sleepiness and the 2 x 1 rotation system (p=0.038), and between sleepiness and hours of sleep under seven (p=0.011). Logistic regression analysis showed that drivers with six or fewer hours of sleep were more likely to have daytime sleepiness (OR 1.83, 95% CI: 1.03-3.25)., Conclusions: . Approximately one out of five drivers experienced daytime sleepiness, which was associated with having six or fewer hours of sleep per day.
- Published
- 2019
- Full Text
- View/download PDF
33. Comparison of classical transrectal prostate biopsy versus cognitive registration in rebiopsy.
- Author
-
Barbas Bernardos G, Herranz Amo F, de Miguel Campos E, Luis Cardo A, Herranz Arriero A, Cancho Gil MJ, Caño Velasco J, Jara Rascón J, Mayor de Castro J, and Hernández Fernández C
- Subjects
- Aged, Biopsy methods, Chi-Square Distribution, Digital Rectal Examination, Humans, Logistic Models, Male, Middle Aged, Prostate diagnostic imaging, Prostatic Neoplasms diagnostic imaging, Retrospective Studies, Ultrasonography methods, Image-Guided Biopsy methods, Magnetic Resonance Imaging, Prostate pathology, Prostatic Neoplasms pathology
- Abstract
Introduction: The aim of this study is to compare performance of two biopsy approaches in patients with at least one previous negative prostate biopsy (PB): classical transrectal biopsy (ClTB) versus cognitive registration biopsy (COG-TB)., Material and Methods: A retrospective study of 205 patients with at least one negative PB. 144 (70.2%) patients underwent a prior mpMRI and 61 (29.8%) patients did not. Nodule classification was carried out according PI-RADS version 2. Peripheral zone (PZ) grouped pZa, pZpl and pZpm areas, transition zone (TZ) Tza, Tzp and Cz areas, and anterior zone (AZ) AS areas. COG-TB was conducted in patients with previous mpMRI (144); while in the remaining 61 (29.8%) patients a ClTB of PZ and TZ was performed. Statistical analysis was performed using Chi square and T-student tests for qualitative and quantitative variables, respectively. Multivariate analysis was carried out in order to identify predictive variables of prostate cancer., Results: Median patient age was 68 (IQR 62-72) years, median PSA was 8.3 (IQR 6.2-11.7) ng/ml and median previous biopsies was 1 (IQR 1-2). Digital rectal examinations (DRE) findings were normal in 169 (82.4%) patients and suspicious in 36 (17.6%) patients (cT2a-b in 34 patients and cT2c in 2). Median prostate volume was 48 (IQR 38-65) cc. Statistically significant differences in PSAD between both groups were found (P=.03). Transrectal ultrasound (TRUS) showed hypoechoic nodules in 8 (13.1%) ClTB patients and in 62 (43.1%) COG-TB patients (P=.0001). The median number of biopsy cylinders per set of prostate biopsies was 10 (IQR 10-10) in ClTB group and 11 (IQR 9-13) in COG-TB group (P=.75). Cancer was diagnosed in 74 (36.1%) patients: of them, 10 (16.4%) were ClTB patients and 64 (44.4%) COG-TB (P=.0001). Tumors classification was as follow: ISUP-1: 34 (45.9%), ISUP-2: 21 (28.4%), ISUP-3: 9 (12.2%), ISUP-4: 7 (9.5%) and ISUP-5: 3 (4.1%). No significant statistical differences were found (P=.89). The median number of biopsy cylinders impaired per set of prostate biopsies was 1 (IQR 1-5) in ClTB group and 2 (IQR 1-4) in COG-TB group (P=.93). Regarding independent predictive variables for prostate cancer the results were: age (OR=12.05; P=.049), suspicious DRE (OR=2.64; P=.04), hypoechoic nodule (OR=2.20; P=.03) and mpMRI +COG-TB sequence (OR=3.49; P=.003)., Conclusions: In patients with at least one negative PB, mpMRI +COG-TB sequence improves 3.5 (OR=3.49) times the diagnosis prostate vs. ClTB., (Copyright © 2018 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
34. Influence of venous tumour extension on local and remote recurrence of stage pT3a pN0 cM0 kidney tumours.
- Author
-
Barbas Bernardos G, Herranz Amo F, Caño Velasco J, Cancho Gil MJ, Mayor de Castro J, Aragón Chamizo J, Polanco Pujol L, and Hernández Fernández C
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Staging, Retrospective Studies, Kidney Neoplasms pathology, Neoplasm Recurrence, Local epidemiology, Neoplastic Cells, Circulating, Renal Veins
- Abstract
Introduction and Objective: One of the inherent features of kidney tumours is the capacity to spread inside the venous system as tumour thrombi. The aim of this study was to assess in patients with stage pT3apN0cM0 kidney cancer whether venous tumour involvement influenced tumour recurrence., Materials and Methods: A retrospective analysis of patients with stage pT3apN0cM0 kidney cancer treated with radical nephrectomy between 1990-2015. Univariate and multivariate Cox regression analysis to identify predictive variables and independent predictive variables relating to recurrence., Results: The results of 153 patients were studied. The median follow-up was 82 (IQR 36-117) months. Recurrence-free survival at 5 years was 58.9% with a median of 97 (95% CI 49.9-144.1) months. Seventy-seven (50.3%) patients recurred. Seventy cases 70 (90.9%) had distant metastases, 17 (14.2%) of these patients had local recurrence in the bed of nephrectomy. Tumour necrosis (p=.0001), and microvascular invasion (p=.001) were identified as independent predictors of tumour recurrence in the multivariable analysis., Conclusions: In our series, after multivariable analysis, venous tumour extension was not related to recurrence. Tumour necrosis and microvascular infiltration did behave as independent predictive factors of tumour recurrence., (Copyright © 2018 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
35. Effectiveness of the «cognitive» biopsy in the diagnosis of prostate cancer in patients with a previous negative biopsy.
- Author
-
Barbas Bernardos G, Herranz Amo F, de Miguel Campos E, Luis Cardo A, Herranz Arriero A, Caño Velasco J, Cancho Gil MJ, Jara Rascón J, Mayor de Castro J, and Hernández Fernández C
- Subjects
- Adenocarcinoma diagnostic imaging, Aged, False Negative Reactions, Humans, Male, Middle Aged, Palpation, Prostate ultrastructure, Prostatic Neoplasms diagnostic imaging, Retrospective Studies, Adenocarcinoma pathology, Biopsy, Large-Core Needle methods, Image-Guided Biopsy methods, Magnetic Resonance Imaging methods, Prostatic Neoplasms pathology
- Abstract
Introduction: Evaluation of the effectiveness of cognitive biopsy (CB) in patients with clinical suspicion of prostate cancer (PC), and at least one negative biopsy (TRB)., Material and Method: Retrospective study of 144 patients with at least one previous TRB and magnetic resonance imaging (MRI). The MRI nodules were classified based on PI-RADS v2 grouping pZa, pZpl and pZpm as the peripheral zone(PZ), Tza, Tzp and CZ as the transitional zone (TZ), and the AS zones as the anterior zone (AZ). A biopsy was indicated for nodules ≥PI-RADS 3. Uni and multivariate analysis was undertaken (logistic regression) to identify variables relating to a PI-RADS 3 tumour on biopsy., Results: The median age was 67 (IQR: 62-72) years, the median PSA was 8.2 (IQR: 6.2-12) ng/ml. A nodule was identified on MRI in the PZ in 97 (67.4%) cases, in the TZ in 29 (20.1%), and in the AZ in 41 (28.5%). PC was diagnosed on biopsy in 64 (44%) patients. The cancer rate in the PI-RADS 3 lesions was 17.5% (7/40), in the PI-RADS 4 47.3% (35/73), and in the PI-RADS 5 lesions it was 73.3% (22/29) (p=.0001). Multivariable analysis with variables that could influence the biopsy result in patients with PI-RADS 3: None (age, PSA, number of previous biopsies, rectal examination, PSAD, prostate volume or number of extracted cylinders) behaved as an independent tumour predictor., Conclusions: The diagnostic performance of CB in patients with at least one previous negative biopsy was 44%, increasing according to the PI-RADS grade, and low in PI-RADS 3. No clinical variable predictive of cancer was found in patients with PI-RADS 3., (Copyright © 2018 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
36. Small Cell Breast Cancer with Lung Metastases.
- Author
-
Cruz Castellanos P, Quintana L, and de Castro J
- Subjects
- Fatal Outcome, Female, Humans, Middle Aged, Breast Neoplasms pathology, Carcinoma, Neuroendocrine secondary, Lung Neoplasms secondary
- Published
- 2018
- Full Text
- View/download PDF
37. Postsurgical complications in patients with renal tumours with venous thrombosis treated with surgery.
- Author
-
Caño-Velasco J, Herranz-Amo F, Barbas-Bernardos G, Mayor-de Castro J, Aragón-Chamizo J, Arnal-Chacón G, Lledó García E, and Hernández-Fernández C
- Subjects
- Aged, Female, Humans, Kidney Neoplasms complications, Kidney Neoplasms pathology, Male, Middle Aged, Neoplastic Cells, Circulating, Retrospective Studies, Venous Thrombosis complications, Kidney Neoplasms surgery, Nephrectomy, Postoperative Complications epidemiology, Renal Veins, Vena Cava, Inferior, Venous Thrombosis surgery
- Abstract
Background and Objective: Surgery on renal tumours with venous thrombosis suffers a high rate of complications and non-negligible perioperative mortality. Our objective was to analyse the postoperative complications, their relationship with the level of the thrombus and its potential predisposing factors., Materials and Methods: A retrospective analysis was conducted of 101 patients with renal tumours with venous thrombosis operated on between 1988 and 2017. Two patients were excluded because of intraoperative pulmonary thromboembolism and exitus (2%). The postsurgical complications were classified according to Clavien-Dindo. To compare the qualitative variables, we employed the chi-squared test. We performed a multivariate analysis using binary logistic regression to identify the independent predictors., Results: Some type of postsurgical complication occurred in 34 (34.3%) patients, 11 (11.1%) of which were severe (Clavien III-V). There were significant differences in the total complications (P=.003) and severe complications (Clavien≥III; P=.03) depending on the level of the tumour thrombus., (Copyright © 2018 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
38. [Locally advanced prostate cancer. Definition, diagnosis and treatment.]
- Author
-
Mayor de Castro J, Caño Velasco J, Aragón Chamizo J, Andrés Boville G, Herranz Amo F, and Hernández Fernández C
- Subjects
- Humans, Male, Neoplasm Staging, Prostatic Neoplasms pathology, Prostatic Neoplasms diagnosis, Prostatic Neoplasms therapy
- Abstract
Prostate cancer is a disease that presents a wide spectrum from low aggressiveness localized to disseminated cancer. Locally advanced prostate cancer (LAPC) is a particularly difficult to manage phase of this spectrum., Objectives: We review the definition, diagnosis and treatment of this phase of the disease., Methods: We performed a non systematic literature review of the most relevant features of this pathology., Results: LAPC is more aggressive than organ confined disease. Its clinical diagnosis is not always easy. Local treatment, in spite of being aggressive with potential sequelae, seems to be advantageous in terms of patient survival., Conclusions: Prostate cancer local staging is currently based on multiparametric magnetic resonance imaging (mpMRI). Local radical treatment with surgery or radiotherapy, with probable addition of systemic treatment, offers promising results for disease control and quality of life improvement.
- Published
- 2018
39. Management Difficulties in a Patient with EGFR-mutation Positive Lung Adenocarcinoma and Cerebral Metastases.
- Author
-
Cruz P, de Lujan L, and de Castro J
- Subjects
- Adenocarcinoma diagnostic imaging, Adenocarcinoma drug therapy, Adenocarcinoma surgery, Antineoplastic Agents therapeutic use, Brain Neoplasms diagnostic imaging, Brain Neoplasms drug therapy, Chemotherapy, Adjuvant, Combined Modality Therapy, Drug Resistance, Neoplasm, Erlotinib Hydrochloride therapeutic use, Humans, Lung Neoplasms drug therapy, Lung Neoplasms surgery, Male, Middle Aged, Positron Emission Tomography Computed Tomography, Protein Kinase Inhibitors therapeutic use, Remission Induction, Solitary Pulmonary Nodule diagnosis, Tomography, X-Ray Computed, Adenocarcinoma secondary, Brain Neoplasms secondary, Genes, erbB-1, Lung Neoplasms pathology, Salvage Therapy
- Published
- 2017
- Full Text
- View/download PDF
40. [Sleep habits and traffic accidents in inter-provincial bus drivers of Arequipa, Peru].
- Author
-
Caso A, Rey de Castro J, and Rosales-Mayor E
- Subjects
- Adult, Humans, Male, Peru epidemiology, Urban Health, Accidents, Traffic statistics & numerical data, Sleep Deprivation epidemiology
- Abstract
In order to determine sleep habits in bus drivers and their relationship to accidents in the city of Arequipa, Peru, a cross-sectional descriptive study was conducted in a non-probabilistic sample of 166 drivers. Driving hours per day were 9.4 ± 3.7. 54% (89) drive over 4 hours without stopping; 74% (123) drive at night; and 87% (145) sleep on the bus. 75% reported fatigue while driving (124). 27% (45) had drowsiness; 24% (40) reported having been in or on the verge of an accident while driving. Sleepiness or fatigue while driving was common in this population and their driving and rest habits could contribute to this.
- Published
- 2014
41. Sleepiness and sleep characteristics in students from an urban district of Lima, Peru.
- Author
-
Huamaní C and Rey de Castro J
- Subjects
- Adolescent, Child, Cities, Cross-Sectional Studies, Female, Humans, Life Style, Male, Peru, Surveys and Questionnaires, Urban Health, Disorders of Excessive Somnolence epidemiology
- Abstract
Introduction: Sleepiness in students has an impact on their learning, focus and memory. Sleepiness is caused by multiple factors. Therefore, our objective was to estimate the frequency of sleepiness in Peruvian students and assess its relation to lifestyle and sleep habits., Methods: Cross-sectional study conducted on first through fifth year secondary students. The Spanish version of the pediatric daytime sleepiness scale (0 to 32 points) was administered and sleep and demographic characteristics and harmful habits, among others were investigated. Excessive sleepiness was considered as a score higher than 20 points, and its association was assessed using raw and adjusted odds ratios., Results: The study included 586 students; the average score in the pediatric daytime sleepiness scale was 13.0 ± 5.5; 11.9% of students had excessive sleepiness. Smoking was associated with excessive sleepiness, with an adjusted OR of 6.9 (95% CI: 2.9-17.0); alcohol consumption showed an OR of 4 (95% CI: 1.5-10.5), and practicing sports showed an OR of 0.5 (95% CI: 0.3-0.9). Likewise, having a bad sleep quality (OR: 5.4; 95% CI: 3.1-9.5) and taking more than 60 minutes to fall asleep (OR: 2.5; 95% CI: 1.16.0) were associated with a higher probability of having sleepiness., Conclusion: Sleepiness was observed in 12% of the studied population, and was found to be lower than the rates described in studies with different populations. Excessive sleepiness is associated with smoking and frequent alcohol consumption, a lower level of sports practice, and bad sleep habits.
- Published
- 2014
- Full Text
- View/download PDF
42. [Restless Legs Syndrome : A Threat to the quality of life].
- Author
-
Castaño-Cárcamo M, Escobar-Cordoba F, and Rey de Castro J
- Subjects
- Analgesics, Opioid therapeutic use, Antiparkinson Agents therapeutic use, Diagnosis, Differential, Dopamine Agonists therapeutic use, Humans, Prevalence, Quality of Life, Restless Legs Syndrome complications, Restless Legs Syndrome diagnosis, Restless Legs Syndrome drug therapy, Restless Legs Syndrome epidemiology, Sleep Deprivation etiology
- Abstract
Restless legs syndrome is a disorder associated with the imperative need to move the legs, starting at different times of day and it gets worse at night, relieved by activity, affecting the quality of life and sleep who sufferers it. Despite being a common disorder at any age, in adults with a prevalence of up to 10%, is not diagnosed by doctors and first level specialists that is why diagnostic and therapeutic interventions get delayed contributing to the perpetuation of symptoms and worsening quality of life. Since its diagnosis is purely clinical, getting familiar with this disorder is essential to ensure proper focus and thus rule out other diseases commonly confused with this one. Restless legs syndrome has a multi-factorial etiology that ranges from a genetic and hereditary, which are called primary restless legs syndrome, to its association with multiple pathologies, known as secondary restless legs syndrome. As for its management, drug therapy and non-drug therapy is aimed at symptom control, as its cure is not possible, although occasionally the condition can refer to later repeat in months or years.
- Published
- 2014
43. Radiological risk and radiation of the percutaneous nephrolithotomy patient.
- Author
-
Husillos A, Mayor de Castro J, Boyano F, Ruiz G, Aragón J, Buenon G, Díez JM, Sierra F, and Hernández-Fernández C
- Subjects
- Dose-Response Relationship, Radiation, Humans, Maximum Allowable Concentration, Radiation Injuries etiology, Radiation Injuries prevention & control, Radiometry instrumentation, Radiometry methods, Risk, Skin radiation effects, Fluoroscopy adverse effects, Nephrostomy, Percutaneous, Radiation Injuries epidemiology, Radiography, Interventional adverse effects
- Published
- 2013
- Full Text
- View/download PDF
44. [Conservative treatment of renal cell carcinoma in kidney transplantation].
- Author
-
González-López R, Bueno-Serrano G, Vázquez-Escuderos JJ, Mayor-De Castro J, and González-Enguita C
- Subjects
- Humans, Carcinoma, Renal Cell surgery, Kidney Neoplasms surgery, Kidney Transplantation, Postoperative Complications surgery
- Abstract
Purpose: To evaluate the new treatment strategies in renal cell carcinoma (RCC) that affects the graft in renal recipients., Acquisition of Evidence: A literature review is made, analyzing all the published cases of conservative surgery in renal graft RCC., Synthesis of Evidence: A total of 51 partial nephrectomies in renal graft patients have been described, with a graft survival rate of 88% and a recurrence rate of 6%. Most of the patients (75%) were asymptomatic at the time of diagnosis, and the mean lesion size was 2.8 cm. Enucleation was the most frequent technique employed. 77% of all immunosuppressor regimens included cyclosporine A. Six patients with graft RCC were subjected to radiofrequency ablation and two patients underwent percutaneous cryoablation, with a single case of relapse and a graft survival rate of 100%., Conclusions: Nephron-sparing surgery is a good management option in renal graft RCC, affording good oncological control and graft survival. Modification of immunosuppression with the withdrawal of cyclosporine A and the introduction of mTOR inhibitors is an adequate measure in such patients., (Copyright © 2012 AEU. Published by Elsevier España, S.L. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
45. [Clinical and polysomnographyc differences between obese and non obese patients with obstructive sleep apnea-hypopnea syndrome].
- Author
-
Rey de Castro J and Rosales-Mayor E
- Subjects
- Female, Humans, Male, Middle Aged, Prospective Studies, Obesity complications, Obesity physiopathology, Polysomnography, Sleep Apnea, Obstructive complications, Sleep Apnea, Obstructive physiopathology
- Abstract
Objectives: To describe the clinical and polysomnographyc differences between obese and non- obese patients with obstructive sleep apnea-hypopnea (OSAH) syndrome., Materials and Methods: A physical examination, the Epworth Sleepiness Scale (ESS) and a polysomnography were performed to all included patients. Obesity was defined as a body mass index (BMI) of ≥ 30 kg/m(2)., Results: 408 patients with OSAH were analyzed, out of these, 119 (47 %) were obese. OSAH was mild in 101 (25 %), moderate in 91 (22 %) and severe in 216 (53 %). There were no age, sex and EES score differences between obese and non-obese patients. Cervical perimeter and sleepiness prevalence according to the ESS were significant higher in obese population. Obese patients had higher comorbidity related to dyslipidemia, high blood pressure and coronary disease. With respect to the polysomnographyc variables, the indexes of respiratory events and the levels of oxygen saturation were worse in obese patients. There were no differences in the other variables. The regression analysis showed association between obesity and OSAH severity., Conclusions: OSAH is a clinical condition not limited to obese population, although this group has a higher comorbidity and OSAH severity.
- Published
- 2011
- Full Text
- View/download PDF
46. [Ezetimibe: caution in the face of doubt].
- Author
-
Araujo F, Mateo de Castro J, and Encinas Barrios C
- Subjects
- Atherosclerosis etiology, Atherosclerosis prevention & control, Azetidines administration & dosage, Azetidines pharmacokinetics, Azetidines therapeutic use, Clinical Trials as Topic statistics & numerical data, Doxazosin therapeutic use, Drug Therapy, Combination, Drug Utilization, Ezetimibe, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Hypercholesterolemia complications, Hypercholesterolemia drug therapy, Hypolipidemic Agents administration & dosage, Hypolipidemic Agents pharmacokinetics, Hypolipidemic Agents therapeutic use, Multicenter Studies as Topic statistics & numerical data, Simvastatin administration & dosage, Simvastatin therapeutic use, United States, Azetidines adverse effects, Hypolipidemic Agents adverse effects, Neoplasms chemically induced
- Published
- 2010
- Full Text
- View/download PDF
47. [Sleep monitoring in bus and truck drivers: relevant factor to consider for the renewal of the driving license].
- Author
-
Rey de Castro J and Rosales-Mayor E
- Subjects
- Humans, Peru, Surveys and Questionnaires, Accidents, Traffic prevention & control, Automobile Driving standards, Occupations, Polysomnography, Sleep Apnea Syndromes complications, Sleep Apnea Syndromes diagnosis, Sleep Deprivation etiology, Sleep Deprivation prevention & control
- Abstract
The available information indicates that up to one third of the road traffic accidents are produced by the driver's sleepiness. Sleep apnea-hypopnea syndrome (SAHS) is an organic disease that causes sleepiness. It can be diagnosed by a sleep register and can be controlled by different therapeutic means, varying their complexity according to its severity, which determines the final cost of the management of SAHS. In patients using the therapy thoroughly, the results are very good and achieve to control the sleepiness, improve the quality of life of the affected subject, protect his health and markedly decrease the risk of accidents due to sleepiness during driving. We put into consideration of the respective authorities the application of these tests in drivers suspected of having SAHS who renew their driving licenses type A-II and A-III.
- Published
- 2010
- Full Text
- View/download PDF
48. [Fatigue and sleepiness in interprovincial road bus drivers: comparative study between formality and informality].
- Author
-
Liendo GR, Castro CL, and Rey de Castro J
- Subjects
- Adult, Cross-Sectional Studies, Humans, Male, Peru, Surveys and Questionnaires, Automobile Driving, Fatigue epidemiology, Occupations, Sleep Deprivation epidemiology
- Abstract
Objectives: To compare the levels of fatigue, sleepiness and their consequences between formal and informal drivers of interprovincial buses. To evaluate labor conditions between both study groups., Materials and Methods: A comparative cross-sectional study was performed with non-probabilistic sampling. 100 companies of land transport were included, out of which 17 were formal according to the official registries of the Ministry of Transport and Communications (MTC), the drivers were also classified as formal or informal. The survey included one questionnaire and a Peruvian validated version of the Epworth sleepiness scale., Results: 71 formal drivers and 274 informal drivers participated, all were males. Out of the 134 drivers that worked for the formal companies according to the MTC, only 43 (32%) belong to the formal group based on the proposed criteria. 48% (34) of the formal drivers and 43% (118) of the informal sleep less than 7 hours a day. 48% (34) of the formal and 49% (135) of the informal admitted having had an accident or "almost" having had it, the most frequent time of the day was between 01.00 and 04.00 in the morning. The dawn is the period in which both groups feel most tired. 44% (30) of the formal drivers and 54% (144) of the informal ones perform 5 or more night shifts per week. Out of the total of interviewed, 16% (56) had sleepiness. The association with road traffic accidents was similar., Conclusions: The fatigue and sleepiness levels were similar between formal and informal drivers. Companies classified as formal, have a high percentage of informality amongst their drivers.
- Published
- 2010
- Full Text
- View/download PDF
49. [Tiredness and sleepiness in rural bus drivers during their job performance: Peruvian experience and proposals].
- Author
-
Rey de Castro J and Rosales-Mayor E
- Subjects
- Accidents, Traffic prevention & control, Cross-Sectional Studies, Humans, Peru, Prospective Studies, Automobile Driving, Fatigue epidemiology, Occupations, Sleep Deprivation epidemiology
- Abstract
The information indicates that the traffic accidents caused by bus drivers' sleepiness or tiredness are frequent in our country. A driver that falls asleep while driving cannot perform evasive maneuvers in order to avoid crashes or getting off the track, being the result of this kind of accidents a great number of victims and infrastructure destruction. In this article we discuss the original data published in Peru up to date and make general proposals to face the problem.
- Published
- 2010
- Full Text
- View/download PDF
50. Comparison of two vaccination strategies against hepatitis A and B in patients with chronic hepatitis C.
- Author
-
Díez Redondo MP, Almaraz A, Jiménez Rodríguez-Vila M, Santamaría A, de Castro J, Torrego JC, and Caro-Patón A
- Subjects
- Adult, Aged, Aged, 80 and over, Cost-Benefit Analysis, Female, Hepatitis A Vaccines administration & dosage, Hepatitis B Vaccines administration & dosage, Humans, Male, Middle Aged, Young Adult, Hepatitis A prevention & control, Hepatitis A Vaccines economics, Hepatitis B prevention & control, Hepatitis B Vaccines economics, Hepatitis C, Chronic
- Abstract
Objective: although the vaccination against hepatitis A (VAH) and hepatitis B (VBH) is recommended in patients with HCV, the most cost-effective strategy has not been established. Our objective was to compare the cost-effectiveness of universal strategy (vaccination all patients) with selective strategy (vaccination only patients against virus they lack immunity to) in patients with HCV., Patients and Methods: we compared the direct medical costs of the two vaccination strategies against both viruses in 313 patients with HC. Serological markers for HAV (anti-HAV) and HBV (HbsAg, anti HBs, anti HBc) were determined in the 313 patients and the costs of the vaccines and the blood tests necessary to determinate the immunity state in our care system were considered., Results: the prevalence of anti-HAV was 81,2% and of anti-HBc was 24,6%. The prevalence of anti-HAV increases with age. HAV vaccination with universal strategy has a cost of 19.806,64 euro and with selective one of 9.899,62 euro. HBV vaccination with universal strategy rose to 18.780 euro and to 20.385,57 euro with selective one (employing anti-HBc). Costs were analysed in different groups of age and several hepatitis HBV risk factors., Conclusions: the selective vaccination strategy against HAV was most cost-effective in our patients with HCV. However, when the prevalence of the anti-HAV decreased to less than 20% universal strategy will be the best option. Difference of cost-effective between the two vaccination strategies against HBV was small, on behalf of universal one, so in groups with higher anti-HBc prevalence, like parenteral drugs users and tattoos, the selective strategy could be the best option.
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.